Market Research Logo

Compounding Pharmacies Market Size By Product (Oral, Topical, Rectal, Parenteral, Inhaler, Ophthalmic), By Application (Paediatric, Adult, Geriatric, Veterinary), By Therapeutic Area (Hormone Replacement, Pain Management), Industry Analysis Report, Region

Compounding Pharmacies Market Size By Product (Oral, Topical, Rectal, Parenteral, Inhaler, Ophthalmic), By Application (Paediatric, Adult, Geriatric, Veterinary), By Therapeutic Area (Hormone Replacement, Pain Management), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, Italy, France, Spain, Russia, Poland, Greece, Ukraine, Sweden, Norway, Belgium, Czech Republic, Finland, China, India, Japan, Singapore, Australia, Brazil, Mexico, Argentina, Saudi Arabia, UAE, South Africa, Qatar, Kuwait), Application Potential, Price Trends, Competitive Market Share & Forecast, 2018 - 2024

Compounding Pharmacies market will reach USD 12.5 billion by 2024; as per a new research report.

Rising prevalence of chronic and non-communicable diseases worldwide will drive compounding pharmacy market growth over the forecast timeframe. Growing elderly population suffering from chronic diseases such as diabetes, asthma and other cardiac disorders coupled with increasing life expectancy across the world will propel the industry growth. Furthermore, increasing aesthetic concerns will fuel the demand for anti-ageing products such as testosterone therapy for men, bioidentical hormone replacement therapy for women and other high quality dermatological products that are produced in compounding pharmacies.

Dearth of cancer drugs or other essential drugs in developed region such as Europe and North America will augment the demand for compounding pharmacies over the forthcoming years. Limited supply of raw materials, production delay by manufacturers and discontinuation of commercialized drug has led to drug shortage. Ability of compounding pharmacies to fill a gap by replicating commercial drugs in case of shortage will fuel the demand for compounded medicines thereby propelling industry growth.

However, the continuous changing regulatory norms and standards will impede the market growth to some extent. Furthermore, high cost of equipment, sterility maintenance and lack of skilled lab technicians and pharmacists will hamper the growth of compounding pharmacies market.

Topical segment will show significant growth over the forecast period owing to the rising prevalence of diabetes worldwide. Growing adoption of unhealthy dietary habits and rising prevalence of obesity are the key factors increasing prevalence of diabetes among the people that subsequently lead to increase in demand of compounded long acting and rapid acting insulin analogs. Moreover, availability of other compounded topical preparations of antidiabetic drugs such as DPP-4 inhibitors and GLP-1 agonists will further witness a significant growth in the future owing to its application in treatment of type II diabetes.

Pediatric segment is estimated to grow at a considerable rate over forecast period owing to growing awareness pertaining to compounding pharmacies and increasing infant morbidity and mortality. Furthermore, customization of medicines to formulate convenient dosage forms for children such as conversion of big, solid pills into easy-to-administer liquid dosage form, will significantly boost the segment growth during analysis period.

Hormone replacement segment will grow at a faster rate during the forecast period due to increasing demand for various anti-ageing products as well hormone replacement theories among adults. Increasing focus of people on excellent quality dermatological products that are compounded as per the patients needs and requirements will further escalate hormone replacement segment growth.

U.S. compounding pharmacies market dominated the industry owing to the presence of geriatric patient pool, developed healthcare facilities and technological advancements. U.S. pharmaceutical industry has witnessed several incidences of drug shortage over the past few years. Increasing drug shortage will certainly boost demand for compounded medications.

Some of the notable industry players are Fagron, B. Braun, Fresenius Kabi, Cantrell Drug Company, McGuff, PharMEDium, Institutional Pharmacy Solutions, Triangle Compounding Pharmacies, Village Compounding Pharmacy, Pencol Compounding Pharmacy and Wedgewood Village Pharmacy. Major industry players are emphasizing on enhancing and strengthening the product portfolio. They are further focusing on partnerships and collaborations to enhance their existing systems.


Report Content
Chapter 1. Methodology
1.1. Methodology
1.1.1. Initial data exploration
1.1.2. Statistical model and forecast
1.1.3. Industry insights and validation
1.1.4. Market definition and forecast parameters
1.2. Data sources
1.2.1. Secondary
1.2.2. Primary
Chapter 2. Executive Summary
2.1. Precision medicine industry 360 degree synopsis, 2013 - 2024
2.1.1. Business trends
2.1.2. Product trends
2.1.3. Application trends
2.1.4. Therapeutic are trends
2.1.5. Regional trends
Chapter 3. Precision Medicine Industry Insights
3.1. Industry segmentation
3.2. Industry size and forecast, 2013 - 2024
3.3. Industry ecosystem analysis
3.3.1. Vendor matrix
3.3.2. Distribution channel analysis
3.4. Industry impact forces
3.4.1. Growth drivers
3.4.1.1. Increasing geriatric population & longevity globally
3.4.1.2. Growing acceptance of personalized medicines worldwide in U.S. and Europe
3.4.1.3. Increasing drug shortage in North America and Europe
3.4.1.4. Convenience of using compounded drugs
3.4.1.5. Growing drug failure rate
3.4.2. Industry pitfalls & challenges
3.4.2.1. Lack of skilled lab technicians and pharmacists in developed countries
3.4.2.2. High costs of equipment and maintenance of sterile environment
3.4.2.3. Changing regulatory specifications
3.4.2.4. Consumers perception towards compounded drugs
3.5. Growth potential analysis
3.5.1. By product
3.5.2. By application
3.5.3. By therapeutic area
3.6. Regulatory landscape
3.6.1. U.S
3.6.2. Europe
3.6.3. Australia
3.7. Reimbursement landscape
3.7.1. U.S.
3.7.2. Europe
3.7.3. Australia
3.8. Cost analysis of compounded medications
3.9. Innovative compounding technologies
3.9.1. Web-based quality management system
3.9.2. Digital tools
3.10. Prescriber insights
3.11. Porter's analysis
3.12. Competitive landscape, 2017
3.12.1. Business overview
3.12.2. Strategy dashboard
3.13. PESTEL analysis
Chapter 4. Compounding Pharmacies Market, By Product
4.1. Global Compounding Pharmacies Market share, by product, 2017 & 2024
4.2. Oral
4.2.1. Market estimates and forecast, by region, 2013 - 2024
4.2.2. Solid preparations
4.2.2.1. Market estimates and forecast, by region, 2013 - 2024
4.2.2.2. Tablets
4.2.2.2.1. Market estimates and forecast, by region, 2013 - 2024
4.2.2.3. Capsules
4.2.2.3.1. Market estimates and forecast, by region, 2013 - 2024
4.2.2.4. Granules
4.2.2.4.1. Market estimates and forecast, by region, 2013 - 2024
4.2.2.5. Powder
4.2.2.5.1. Market estimates and forecast, by region, 2013 - 2024
4.2.2.6. Others
4.2.2.6.1. Market estimates and forecast, by region, 2013 - 2024
4.2.3. Liquid preparations
4.2.3.1. Market estimates and forecast, by region, 2013 - 2024
4.2.3.2. Solutions
4.2.3.2.1. Market estimates and forecast, by region, 2013 - 2024
4.2.3.3. Suspension
4.2.3.3.1. Market estimates and forecast, by region, 2013 - 2024
4.2.3.4. Emulsion
4.2.3.4.1. Market estimates and forecast, by region, 2013 - 2024
4.2.3.5. Syrup
4.2.3.5.1. Market estimates and forecast, by region, 2013 - 2024
4.2.3.6. Others
4.2.3.6.1. Market estimates and forecast, by region, 2013 - 2024
4.3. Topical
4.3.1. Market estimates and forecast, by region, 2013 - 2024
4.3.2. Ointments
4.3.2.1. Market estimates and forecast, by region, 2013 - 2024
4.3.3. Creams
4.3.3.1. Market estimates and forecast, by region, 2013 - 2024
4.3.4. Gels
4.3.4.1. Market estimates and forecast, by region, 2013 - 2024
4.3.5. Pastes
4.3.5.1. Market estimates and forecast, by region, 2013 - 2024
4.3.6. Others
4.3.6.1. Market estimates and forecast, by region, 2013 - 2024
4.4. Rectal
4.4.1. Market estimates and forecast, by region, 2013 - 2024
4.4.2. Suppositories
4.4.2.1. Market estimates and forecast, by region, 2013 - 2024
4.4.3. Edema
4.4.3.1. Market estimates and forecast, by region, 2013 - 2024
4.4.4. Others
4.4.4.1. Market estimates and forecast, by region, 2013 - 2024
4.5. Parenteral
4.5.1. Market estimates and forecast, by region, 2013 - 2024
4.6. Inhaler
4.6.1. Market estimates and forecast, by region, 2013 - 2024
4.7. Ophthalmic
4.7.1. Market estimates and forecast, by region, 2013 - 2024
4.7.1.1. Eye drops
4.7.1.1.1. Market estimates and forecast, by region, 2013 - 2024
4.7.1.2. Ear drops
4.7.1.2.1. Market estimates and forecast, by region, 2013 - 2024
4.7.1.3. Nasal drops
4.7.1.3.1. Market estimates and forecast, by region, 2013 - 2024
4.7.1.4. Others
4.7.1.4.1. Market estimates and forecast, by region, 2013 - 2024
Chapter 5. Compounding Pharmacies Market, By Application
5.1. Global Compounding Pharmacies Market share, by application, 2017 & 2024
5.2. Pediatrics
5.2.1. Market estimates and forecast, by region, 2013 - 2024
5.3. Adult
5.3.1. Market estimates and forecast, by region, 2013 - 2024
5.4. Geriatric
5.4.1. Market estimates and forecast, by region, 2013 - 2024
5.5. Veterinary
5.5.1. Market estimates and forecast, by region, 2013 - 2024
Chapter 6. Compounding Pharmacies Market, By Therapeutic Area
6.1. Global Compounding Pharmacies Market share, by therapeutic area, 2017 & 2024
6.2. Hormone Replacement
6.2.1. Market estimates and forecast, by region, 2013 - 2024
6.3. Pain Management
6.3.1. Market estimates and forecast, by region, 2013 - 2024
Chapter 7. Compounding Pharmacies Market, By Region
7.1. Compounding Pharmacies Market share, by region, 2017 & 2024
7.2. North America
7.2.1. Market estimates and forecast, by country, 2013 - 2024
7.2.2. Market estimates and forecast, by product, 2013 - 2024
7.2.3. Market estimates and forecast, by application, 2013 - 2024
7.2.4. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.2.5. U.S.
7.2.5.1. Market estimates and forecast, by product, 2013 - 2024
7.2.5.2. Market estimates and forecast, by application, 2013 - 2024
7.2.5.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.2.6. Canada
7.2.6.1. Market estimates and forecast, by product, 2013 - 2024
7.2.6.2. Market estimates and forecast, by application, 2013 - 2024
7.2.6.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3. Europe
7.3.1. Market estimates and forecast, by country, 2013 - 2024
7.3.2. Market estimates and forecast, by product, 2013 - 2024
7.3.3. Market estimates and forecast, by application, 2013 - 2024
7.3.4. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.5. Germany
7.3.5.1. Market estimates and forecast, by product, 2013 - 2024
7.3.5.2. Market estimates and forecast, by application, 2013 - 2024
7.3.5.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.6. UK
7.3.6.1. Market estimates and forecast, by product, 2013 - 2024
7.3.6.2. Market estimates and forecast, by application, 2013 - 2024
7.3.6.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.7. Italy
7.3.7.1. Market estimates and forecast, by product, 2013 - 2024
7.3.7.2. Market estimates and forecast, by application, 2013 - 2024
7.3.7.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.8. Spain
7.3.8.1. Market estimates and forecast, by product, 2013 - 2024
7.3.8.2. Market estimates and forecast, by application, 2013 - 2024
7.3.8.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.9. France
7.3.9.1. Market estimates and forecast, by product, 2013 - 2024
7.3.9.2. Market estimates and forecast, by application, 2013 - 2024
7.3.9.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.10. Poland
7.3.10.1. Market estimates and forecast, by product, 2013 - 2024
7.3.10.2. Market estimates and forecast, by application, 2013 - 2024
7.3.10.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.11. Ukraine
7.3.11.1. Market estimates and forecast, by product, 2013 - 2024
7.3.11.2. Market estimates and forecast, by application, 2013 - 2024
7.3.11.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.12. Greece
7.3.12.1. Market estimates and forecast, by product, 2013 - 2024
7.3.12.2. Market estimates and forecast, by application, 2013 - 2024
7.3.12.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.13. Sweden
7.3.13.1. Market estimates and forecast, by product, 2013 - 2024
7.3.13.2. Market estimates and forecast, by application, 2013 - 2024
7.3.13.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.14. Norway
7.3.14.1. Market estimates and forecast, by product, 2013 - 2024
7.3.14.2. Market estimates and forecast, by application, 2013 - 2024
7.3.14.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.15. Belgium
7.3.15.1. Market estimates and forecast, by product, 2013 - 2024
7.3.15.2. Market estimates and forecast, by application, 2013 - 2024
7.3.15.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.16. Czech Republic
7.3.16.1. Market estimates and forecast, by product, 2013 - 2024
7.3.16.2. Market estimates and forecast, by application, 2013 - 2024
7.3.16.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.17. Finland
7.3.17.1. Market estimates and forecast, by product, 2013 - 2024
7.3.17.2. Market estimates and forecast, by application, 2013 - 2024
7.3.17.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.3.18. Russia
7.3.18.1. Market estimates and forecast, by product, 2013 - 2024
7.3.18.2. Market estimates and forecast, by application, 2013 - 2024
7.3.18.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.4. Asia Pacific
7.4.1. Market estimates and forecast, by country, 2013 - 2024
7.4.2. Market estimates and forecast, by product, 2013 - 2024
7.4.3. Market estimates and forecast, by application, 2013 - 2024
7.4.4. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.4.5. China
7.4.5.1. Market estimates and forecast, by product, 2013 - 2024
7.4.5.2. Market estimates and forecast, by application, 2013 - 2024
7.4.5.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.4.6. India
7.4.6.1. Market estimates and forecast, by product, 2013 - 2024
7.4.6.2. Market estimates and forecast, by application, 2013 - 2024
7.4.6.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.4.7. Japan
7.4.7.1. Market estimates and forecast, by product, 2013 - 2024
7.4.7.2. Market estimates and forecast, by application, 2013 - 2024
7.4.7.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.4.8. Singapore
7.4.8.1. Market estimates and forecast, by product, 2013 - 2024
7.4.8.2. Market estimates and forecast, by application, 2013 - 2024
7.4.8.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.4.9. Australia
7.4.9.1. Market estimates and forecast, by product, 2013 - 2024
7.4.9.2. Market estimates and forecast, by application, 2013 - 2024
7.4.9.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.5. Latin America
7.5.1. Market estimates and forecast, by country, 2013 - 2024
7.5.2. Market estimates and forecast, by product, 2013 - 2024
7.5.3. Market estimates and forecast, by application, 2013 - 2024
7.5.4. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.5.5. Argentina
7.5.5.1. Market estimates and forecast, by product, 2013 - 2024
7.5.5.2. Market estimates and forecast, by application, 2013 - 2024
7.5.5.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.5.6. Brazil
7.5.6.1. Market estimates and forecast, by product, 2013 - 2024
7.5.6.2. Market estimates and forecast, by application, 2013 - 2024
7.5.6.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.5.7. Mexico
7.5.7.1. Market estimates and forecast, by product, 2013 - 2024
7.5.7.2. Market estimates and forecast, by application, 2013 - 2024
7.5.7.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.6. Middle East & Africa
7.6.1. Market estimates and forecast, by country, 2013 - 2024
7.6.2. Market estimates and forecast, by product, 2013 - 2024
7.6.3. Market estimates and forecast, by application, 2013 - 2024
7.6.4. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.6.5. South Africa
7.6.5.1. Market estimates and forecast, by product, 2013 - 2024
7.6.5.2. Market estimates and forecast, by application, 2013 - 2024
7.6.5.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.6.6. UAE
7.6.6.1. Market estimates and forecast, by product, 2013 - 2024
7.6.6.2. Market estimates and forecast, by application, 2013 - 2024
7.6.6.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.6.7. Saudi Arabia
7.6.7.1. Market estimates and forecast, by product, 2013 - 2024
7.6.7.2. Market estimates and forecast, by application, 2013 - 2024
7.6.7.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.6.8. Qatar
7.6.8.1. Market estimates and forecast, by product, 2013 - 2024
7.6.8.2. Market estimates and forecast, by application, 2013 - 2024
7.6.8.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
7.6.9. Kuwait
7.6.9.1. Market estimates and forecast, by product, 2013 - 2024
7.6.9.2. Market estimates and forecast, by application, 2013 - 2024
7.6.9.3. Market estimates and forecast, by therapeutic area, 2013 - 2024
Chapter 8. Company Profiles
8.1. B.Braun Medical
8.1.1. Business overview
8.1.2. Financial data
8.1.3. Product landscape
8.1.4. Strategic outlook
8.1.5. SWOT analysis
8.2. Cantrell Drug company
8.2.1. Business overview
8.2.2. Financial data
8.2.3. Product landscape
8.2.4. Strategic outlook
8.2.5. SWOT analysis
8.3. Doughtery's Pharmacy
8.3.1. Business overview
8.3.2. Financial data
8.3.3. Product landscape
8.3.4. Strategic outlook
8.3.5. SWOT analysis
8.4. Fagron
8.4.1. Business overview
8.4.2. Financial data
8.4.3. Product landscape
8.4.4. Strategic outlook
8.4.5. SWOT analysis
8.5. Fresenuis Kabi
8.5.1. Business overview
8.5.2. Financial data
8.5.3. Product landscape
8.5.4. Strategic outlook
8.5.5. SWOT analysis
8.6. Institutional Pharmacy solutions
8.6.1. Business overview
8.6.2. Financial data
8.6.3. Product landscape
8.6.4. Strategic outlook
8.6.5. SWOT analysis
8.7. ITC Compounding Pharmacy
8.7.1. Business overview
8.7.2. Financial data
8.7.3. Product landscape
8.7.4. Strategic outlook
8.7.5. SWOT analysis
8.8. Lorraine's Pharmacy
8.8.1. Business overview
8.8.2. Financial data
8.8.3. Product landscape
8.8.4. Strategic outlook
8.8.5. SWOT analysis
8.9. Mcguff compounding pharmacy services
8.9.1. Business overview
8.9.2. Financial data
8.9.3. Product landscape
8.9.4. Strategic outlook
8.9.5. SWOT analysis
8.10. Pencol Compounding Pharmacy
8.10.1. Business overview
8.10.2. Financial data
8.10.3. Product landscape
8.10.4. Strategic outlook
8.10.5. SWOT analysis
8.11. PharmMEDium
8.11.1. Business overview
8.11.2. Financial data
8.11.3. Product landscape
8.11.4. Strategic outlook
8.11.5. SWOT analysis
8.12. Rx3 Compounding Pharmacy
8.12.1. Business overview
8.12.2. Financial data
8.12.3. Product landscape
8.12.4. Strategic outlook
8.12.5. SWOT analysis
8.13. Triangle compounding Pharmacies
8.13.1. Business overview
8.13.2. Financial data
8.13.3. Product landscape
8.13.4. Strategic outlook
8.13.5. SWOT analysis
8.14. Village compounding Pharmacies
8.14.1. Business overview
8.14.2. Financial data
8.14.3. Product landscape
8.14.4. Strategic outlook
8.14.5. SWOT analysis
8.15. Wedgewood Village Pharmacy
8.15.1. Business overview
8.15.2. Financial data
8.15.3. Product landscape
8.15.4. Strategic outlook
8.15.5. SWOT analysis
Data Tables
TABAL 1. Compounding pharmacies industry 360 degree synopsis, 2013 - 2024
TABAL 2. Global compounding pharmacies market, 2013 - 2024 (USD Million)
TABAL 3. Global compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 4. Global compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 5. Global compounding pharmacies market, by therapeutic area, 2013 - 2024 (USD Million)
TABAL 6. Global compounding pharmacies market, by region, 2013 - 2024 (USD Million)
TABAL 7. Industry impact forces
TABAL 8. Oral market by region, 2013 - 2024 (USD Million)
TABAL 9. Compounding pharmacies solid preparations market, by region, 2013 - 2024, (USD Mn)
TABAL 10. Compounding pharmacies tablets market, by region, 2013 - 2024, (USD Million)
TABAL 11. Compounding pharmacies market capsules market, by region, 2013 - 2024, (USD Million)
TABAL 12. Compounding pharmacies granules market, by region, 2013 - 2024, (USD Million)
TABAL 13. Compounding pharmacies powder market, by region, 2013 - 2024, (USD Million)
TABAL 14. Compounding pharmacies others market, by region, 2013 - 2024, (USD Million)
TABAL 15. Compounding pharmacies liquid preparations market, by region, 2013 - 2024, (USD Million)
TABAL 16. Compounding pharmacies solutions market, by region, 2013 - 2024, (USD Million)
TABAL 17. Compounding pharmacies market suspension market, by region, 2013 - 2024, (USD Mn)
TABAL 18. Compounding pharmacies emulsion market, by region, 2013 - 2024, (USD Million)
TABAL 19. Compounding pharmacies syrup market, by region, 2013 - 2024, (USD Million)
TABAL 20. Compounding pharmacies others market, by region, 2013 - 2024, (USD Million)
TABAL 21. Topical market, by region, 2013 - 2024, (USD Million)
TABAL 22. Compounding pharmacies ointments market, by region, 2013 - 2024, (USD Million)
TABAL 23. Compounding pharmacies creams market, by region, 2013 - 2024, (USD Million)
TABAL 24. Compounding pharmacies gels market, by region, 2013 - 2024, (USD Million)
TABAL 25. Compounding pharmacies pastes market, by region, 2013 - 2024, (USD Million)
TABAL 26. Compounding pharmacies others market, 2013 - 2024, (USD Million)
TABAL 27. Rectal market by region, 2013 - 2024 (USD Million)
TABAL 28. Compounding pharmacies suppositories market, by region, 2013 - 2024, (USD Mn)
TABAL 29. Compounding pharmacies enema market, by region, 2013 - 2024, (USD Million)
TABAL 30. Compounding pharmacies others market, by region, 2013 - 2024, (USD Million)
TABAL 31. Parenteral market by region, 2013 - 2024 (USD Million)
TABAL 32. Inhaler market by region, 2013 - 2024 (USD Million)
TABAL 33. Ophthalmic market by region, 2013 - 2024 (USD Million)
TABAL 34. Compounding pharmacies eye drops market, by region, 2013 - 2024, (USD Million)
TABAL 35. Compounding pharmacies ears drops market, by region, 2013 - 2024, (USD Million)
TABAL 36. Compounding pharmacies nasal drops market, by region, 2013 - 2024, (USD Million)
TABAL 37. Compounding pharmacies others market, by region, 2013 - 2024, (USD Million)
TABAL 38. Pediatric compounding pharmacies market, by region, 2013 - 2024, (USD Million)
TABAL 39. Adult compounding pharmacies market, by region 2013 - 2024, (USD Million)
TABAL 40. Geriatric compounding pharmacies market, by region 2013 - 2024, (USD Million)
TABAL 41. Veterinary compounding pharmacies market, by region 2013 - 2024, (USD Million)
TABAL 42. Hormone replacement compounding pharmacies market, by region, 2013 - 2024, (USD Mn)
TABAL 43. Pain management compounding pharmacies market, by region, 2013 - 2024, (USD Million)
TABAL 44. North America compounding pharmacies market, by country, 2013 - 2024 (USD Million)
TABAL 45. North America compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 46. North America compounding pharmacies market, by application, 2013 - 2024 (USD Mn)
TABAL 47. North America compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 48. U.S. compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 49. U.S. compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 50. U.S. compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 51. Canada compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 52. Canada compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 53. Canada compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 54. Europe compounding pharmacies market, by country 2013 - 2024 (USD Million)
TABAL 55. Europe compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 56. Europe compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 57. Europe compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 58. Germany compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 59. Germany compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 60. Germany compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 61. UK compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 62. UK compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 63. UK compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 64. Italy compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 65. Italy compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 66. Italy compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 67. Spain compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 68. Spain compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 69. Spain compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 70. France compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 71. France compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 72. France compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 73. Poland compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 74. Poland compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 75. Poland compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 76. Ukraine compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 77. Ukraine compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 78. Ukraine compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 79. Greece compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 80. Greece compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 81. Greece compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 82. Sweden compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 83. Sweden compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 84. Sweden compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 85. Norway compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 86. Norway compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 87. Norway compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 88. Belgium compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 89. Belgium compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 90. Belgium compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 91. Czech Republic compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 92. Czech Republic compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 93. Czech Republic compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 94. Finland compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 95. Finland compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 96. Finland compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 97. Russia compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 98. Russia compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 99. Russia compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 100. Asia Pacific compounding pharmacies market, by country, 2013 - 2024 (USD Million)
TABAL 101. Asia Pacific compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 102. Asia Pacific compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 103. Asia Pacific compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 104. China compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 105. China compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 106. China compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 107. India compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 108. India compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 109. India compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 110. Japan compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 111. Japan compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 112. Japan compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 113. Singapore compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 114. Singapore compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 115. Singapore compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 116. Australia compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 117. Australia compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 118. Australia compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 119. Latin America compounding pharmacies market, by country 2013 - 2024 (USD Million)
TABAL 120. Latin America compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 121. Latin America compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 122. Latin America compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 123. Argentina compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 124. Argentina compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 125. Argentina compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 126. Brazil compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 127. Brazil compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 128. Brazil compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 129. Mexico compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 130. Mexico compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 131. Mexico compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 132. MEA compounding pharmacies market, by country 2013 - 2024 (USD Million)
TABAL 133. MEA compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 134. MEA compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 135. MEA compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 136. South Africa compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 137. South Africa compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 138. South Africa compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 139. UAE compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 140. UAE compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 141. UAE compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)
TABAL 142. Saudi Arabia compounding pharmacies market, by product, 2013 - 2024 (USD Million)
TABAL 143. Saudi Arabia compounding pharmacies market, by application, 2013 - 2024 (USD Million)
TABAL 144. Saudi Arabia compounding pharmacies market, by therapeutic areas, 2013 - 2024 (USD Million)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report